IMAGIN Competitors

DPD3 Stock

EUR 0.0005 0.00 0.00%

IMAGIN MEDICAL INC competes with Abbott Laboratories, Medtronic PLC, Stryker, Boston Scientific, and Edwards Lifesciences; as well as few others. The company operates under Healthcare sector and is part of Medical Devices industry. Analyzing IMAGIN MEDICAL competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of IMAGIN MEDICAL to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out IMAGIN MEDICAL Correlation with its peers.

You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of IMAGIN MEDICAL competition on your existing holdings.

Specify up to 10 symbols:

Hype

Prediction

Low	Estimated	High
0.00	0.0005	0.00

Details

Intrinsic

Valuation

Low	Real	High
0.00	0.0004	0.00

Details

Naive

Forecast

Low	Next	High
0.0005	0.0005	0.0005

Details

Bollinger

Band Projection (param)

Lower	Middle Band	Upper
0.0005	0.0005	0.0005

Details

Please note, it is not enough to conduct a financial or market analysis of a single entity such as IMAGIN MEDICAL. Your research has to be compared to or analyzed against IMAGIN MEDICAL's peers to derive any actionable benefits. When done correctly, IMAGIN MEDICAL's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in IMAGIN MEDICAL INC.

IMAGIN MEDICAL Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between IMAGIN MEDICAL and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of IMAGIN and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of IMAGIN MEDICAL INC does not affect the price movement of the other competitor.

	ABL	2M6	SYK	BSX	EWL	AFW
ABL		0.5	0.85	0.87	0.77	-0.39	ABL
2M6	0.5		0.3	0.44	0.22	-0.63	2M6
SYK	0.85	0.3		0.88	0.68	-0.17	SYK
BSX	0.87	0.44	0.88		0.67	-0.2	BSX
EWL	0.77	0.22	0.68	0.67		-0.17	EWL
AFW	-0.39	-0.63	-0.17	-0.2	-0.17		AFW
	ABL	2M6	SYK	BSX	EWL	AFW

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

High positive correlations

BSX	+ 0.88	SYK
BSX	+ 0.87	ABL
SYK	+ 0.85	ABL
EWL	+ 0.77	ABL
EWL	+ 0.68	SYK
EWL	+ 0.67	BSX

High negative correlations

AFW	- 0.63	2M6
AFW	- 0.39	ABL
AFW	- 0.2	BSX
AFW	- 0.17	EWL
AFW	- 0.17	SYK

Risk-Adjusted Indicators

There is a big difference between IMAGIN Stock performing well and IMAGIN MEDICAL Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze IMAGIN MEDICAL's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
ABL	0.96	0.19	0.06	(2.87)	0.88	(1.15)	2.39	(1.53)	7.61
2M6	0.82	0.01	(0.05)	0.15	1.06	(0.87)	1.72	(1.65)	7.08
SYK	1.05	0.23	0.06	(2.10)	1.14	(1.13)	2.36	(2.30)	7.26
BSX	1.25	0.27	0.06	(1.70)	1.54	(1.53)	2.68	(1.99)	8.84
EWL	1.35	0.14	0.01	(1.46)	1.51	(1.51)	3.05	(2.70)	8.45
AFW	1.58	0.02	(0.03)	0.18	1.74	(1.82)	3.35	(2.65)	12.53

Unable to evaluate fundamental data of [ABL.F, 2M6.F, SYK.F, BSX.F, EWL.F, AFW.F] at this time. Please try again later

All Fundamental Data

IMAGIN MEDICAL Competitive Analysis

The better you understand IMAGIN MEDICAL competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, IMAGIN MEDICAL's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across IMAGIN MEDICAL's competition over several years is one of the best ways to analyze its investment potential.

Better Than Average

Worse Than Peers

View Performance Chart

	DPD3	ABL	2M6	SYK	BSX	EWL	AFW
	0.00 0.0005 IMAGIN	0.02 112.84 Abbott	0.89 81.65 Medtronic	2.32 371.20 Stryker	0.60 84.50 Boston	0.68 68.26 Edwards	0.69 215.80 Align
Market Volatility (90 Days Market Risk)	Very steady	Very steady	Very steady	Very steady	Out of control	Very steady	Very steady
Market Performance (90 Days Performance)	Very Weak	OK	Insignificant	Good	Good	Modest	Weak
Odds of Financial Distress (Probability Of Bankruptcy)	Quite High	Low	Low	Low	Low	Low	Low
Current Valuation (Equity Enterprise Value)	Over Valued	Over Valued	Over Valued	Over Valued	Under Valued	Over Valued	Fairly Valued
Buy or Sell Advice (Average Analysts Consensus)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available
Trade Advice (90 Days Macroaxis Advice)	Strong Sell	Strong Sell	Hold	Strong Sell	Not Rated	Strong Sell	Cautious Hold
Current Ratio	2.31 X	1.75 X	2.59 X	2.07 X	1.66 X	3.66 X	1.85 X
Net Asset	N/A	74.44 B	90.98 B	36.88 B	32.47 B	8.29 B	5.95 B
Profit Margin	N/A	0.16 %	0.13 %	0.13 %	0.06 %	0.28 %	0.1 %
EBITDA	(3.4 M)	12.13 B	8.78 B	4.04 B	2.75 B	1.93 B	779.84 M
Operating Margin	N/A	0.20 %	0.22 %	0.19 %	0.16 %	0.33 %	0.18 %
Current Valuation	N/A	190.22 B	113.84 B	101.82 B	72.27 B	43.48 B	13.59 B
Price To Book	N/A	5.40 X	1.99 X	5.77 X	3.80 X	7.49 X	4.09 X
Five Year Return	N/A	1.70 %	1.80 %	1.10 %	N/A	N/A	N/A
Beta	1.66	0.65	0.73	0.94	0.79	1.0	1.62
Number Of Employees	N/A	115 K	95 K	51 K	45 K	17.3 K	10
Shares Outstanding	10.83 M	1.74 B	1.33 B	378.83 M	1.43 B	608.31 M	76.61 M
Cash Flow From Operations	(2.76 M)	9.58 B	7.35 B	2.62 B	1.53 B	1.22 B	568.73 M
Annual Yield	N/A	0.02 %	0.03 %	0.01 %	N/A	N/A	N/A
Total Debt	4 M	14.52 B	20.37 B	11.86 B	8.91 B	596.3 M	59.14 M
Return On Equity	N/A	0.19	0.0784	0.15	0.0408	0.26	0.1
Z Score	N/A	6.6	3.0	4.2	4.2	46.8	N/A
Return On Asset	-2.03	0.0738	0.0449	0.0618	0.0393	0.13	0.0691
Book Value Per Share	(1.23) X	21.11 X	38.67 X	43.88 X	12.26 X	9.55 X	46.45 X
Total Asset	N/A	74.44 B	90.98 B	36.88 B	32.47 B	8.29 B	5.95 B
Debt To Equity	N/A	0.55 %	50.40 %	74.20 %	0.59 %	19.30 %	4.30 %
Target Price	N/A	132.05	145.56	287.72	N/A	119.36	743.46
Last Dividend Paid	N/A	1.92	2.67	2.84	N/A	N/A	N/A
Shares Owned By Institutions	N/A	76.37 %	84.51 %	80.48 %	94.00 %	86.92 %	90.97 %
Market Capitalization	1.87 M	167.05 B	103.37 B	92.13 B	62.45 B	47.01 B	22.27 B
Price To Earning	N/A	41.25 X	26.98 X	20.44 X	317.20 X	45.19 X	36.83 X
Price To Earnings To Growth	N/A	18.63 X	3.00 X	2.82 X	2.51 X	3.05 X	10.68 X
Price To Sales	N/A	3.91 X	3.15 X	4.90 X	4.91 X	8.30 X	3.76 X
Net Income	(4.15 M)	6.93 B	5.04 B	2.36 B	698 M	1.52 B	361.57 M
Earnings Per Share	(0.86) X	3.69 X	2.89 X	5.83 X	0.42 X	2.35 X	4.42 X
Shares Owned By Insiders	12.46 %	0.70 %	0.09 %	1.79 %	0.20 %	0.82 %	6.49 %
Revenue	N/A	43.65 B	31.69 B	18.45 B	12.68 B	5.38 B	3.73 B
Cash And Equivalents	991.24 K	8.37 B	9.85 B	1.84 B	2.68 B	963 M	720.92 M
Cash Per Share	0.11 X	4.71 X	7.35 X	4.92 X	1.88 X	4.62 X	9.02 X
Gross Profit	N/A	24.58 B	21.71 B	11.65 B	8.68 B	4.3 B	2.64 B
Day Typical Price	5.0E-4	112.72	81.75	370.07	84.67	67.94	215.8
Accumulation Distribution	N/A	0.0032	0.012	0.0124	0.0059	0.0141	N/A
Market Facilitation Index	N/A	0.36	0.99	4.6	0.5	0.96	N/A
Daily Balance Of Power	0.0	(0.06)	0.7273	1.826087	1.0	0.4792	(9,223,372,036,855)
Period Momentum Indicator	N/A	(0.02)	0.72	8.4	0.5	0.46	(1.50)
Rate Of Daily Change	1.0	1.0	1.01	1.02	1.01	1.01	0.99
Day Median Price	5.0E-4	112.66	81.81	369.5	84.75	67.78	215.8
Price Action Indicator	N/A	0.17	0.21	5.9	N/A	0.71	(0.75)
Relative Strength Index	N/A	61.44	48.42	62.59	58.65	62.45	57.48
Coefficient Of Variation	N/A	725.38	1630.84	635.07	640.41	1204.25	2634.52
Mean Deviation	N/A	0.9584	0.8242	1.05	1.25	1.35	1.58
Jensen Alpha	N/A	0.1878	0.0105	0.227	0.2681	0.1442	0.0231
Total Risk Alpha	N/A	(0.04)	(0.12)	(0.01)	(0.01)	(0.14)	(0.25)
Sortino Ratio	N/A	0.0551	(0.05)	0.0639	0.0633	0.0077	(0.03)
Downside Variance	N/A	1.18	1.33	2.18	4.21	2.76	3.4
Standard Deviation	N/A	1.38	1.11	1.43	1.67	1.72	2.05
Kurtosis	N/A	4.6	1.76	0.7218	2.4	(0.08)	1.55
Potential Upside	N/A	2.39	1.72	2.36	2.68	3.05	3.35
Treynor Ratio	N/A	(2.87)	0.147	(2.10)	(1.70)	(1.46)	0.1827
Maximum Drawdown	N/A	7.61	7.08	7.26	8.84	8.45	12.53
Variance	N/A	1.9	1.23	2.04	2.78	2.97	4.2
Market Risk Adjusted Performance	N/A	(2.86)	0.157	(2.09)	(1.69)	(1.45)	0.1927
Risk Adjusted Performance	N/A	0.1098	0.05	0.125	0.1248	0.069	0.0353
Skewness	N/A	1.29	(0.26)	0.1307	(0.84)	0.1132	0.5822
Semi Deviation	N/A	0.8827	1.06	1.14	1.54	1.51	1.74
Information Ratio	N/A	0.0433	(0.06)	0.0661	0.0779	0.0074	(0.03)
Value At Risk	N/A	(1.53)	(1.65)	(2.30)	(1.99)	(2.70)	(2.65)
Expected Short fall	N/A	(1.15)	(0.87)	(1.13)	(1.53)	(1.51)	(1.82)
Downside Deviation	N/A	1.08	1.15	1.48	2.05	1.66	1.84
Semi Variance	N/A	0.7791	1.13	1.29	2.37	2.28	3.03

IMAGIN MEDICAL Competition Performance Charts

Five steps to successful analysis of IMAGIN MEDICAL Competition

IMAGIN MEDICAL's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by IMAGIN MEDICAL INC in relation to its competition. IMAGIN MEDICAL's competition analysis typically involves several steps, including:

Identifying the key players in the market: This involves identifying the major competitors of IMAGIN MEDICAL in the market, both direct and indirect, as well as new entrants and disruptive technologies.
Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact IMAGIN MEDICAL's competitive landscape.
Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to IMAGIN MEDICAL INC, and developing a strategy to address them.
Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.

Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your IMAGIN MEDICAL position

In addition to having IMAGIN MEDICAL in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Pharmaceutical Products Thematic Idea Now

Pharmaceutical Products

Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Pharmaceutical Products theme has 61 constituents at this time.

You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Pharmaceutical Products Theme or any other thematic opportunities.

View All Next

Launch

Other Information on Investing in IMAGIN Stock

IMAGIN MEDICAL financial ratios help investors to determine whether IMAGIN Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in IMAGIN with respect to the benefits of owning IMAGIN MEDICAL security.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

IMAGIN Competitors

Specify up to 10 symbols:

IMAGIN MEDICAL Competition Correlation Matrix

Risk-Adjusted Indicators

IMAGIN MEDICAL Competitive Analysis

IMAGIN MEDICAL Competition Performance Charts

Five steps to successful analysis of IMAGIN MEDICAL Competition

Complement your IMAGIN MEDICAL position

Did You Try This Idea?

Run Pharmaceutical Products Thematic Idea Now

Pharmaceutical Products

Other Information on Investing in IMAGIN Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY